Healthy potentially undervalued

Results

2434

Companies which are potentially undervalued and in an acceptable financial position.

2434 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	CABKA	€2.02	1.0%	3.1%	€49.9m	€3.28	0.3	105.5%	0%	Materials
	EMBLA	DKK 26.50	-0.7%	-20.4%	DKK 11.3b	DKK 33.30	20.2	11.9%	0%	Healthcare
	VTURA	NOK 29.90	0.7%	63.8%	NOK 3.1b	NOK 42.42	3.3	9.1%	n/a	Energy
	TESB	€20.70	1.7%	-17.9%	€1.2b	€25.50	0.4	69.5%	3.6%	Materials
	FGR	€130.85	3.4%	15.6%	€12.4b	€161.21	12.2	7.3%	3.7%	Capital Goods
	PCZ	€8.58	4.3%	-6.5%	€510.6m	€14.73	0.5	20.9%	5.5%	Banks
	FOUR	UK£37.40	0.5%	5.5%	UK£1.0b	UK£49.23	12.2	-5.3%	4.8%	Media
	ICG	UK£17.26	-3.0%	-10.7%	UK£4.8b	UK£24.21	10.0	10.4%	5.0%	Diversified Financials
	EGLA	€1.02	-2.9%	-54.2%	€164.1m	€1.23	0.2	100.8%	4.1%	Capital Goods
	PHM	€69.50	3.7%	-14.9%	€1.2b	€106.11	15.0	31.7%	1.2%	Pharmaceuticals & Biotech
	DEME	€180.60	-5.2%	35.0%	€4.6b	€221.75	13.2	4.7%	2.5%	Capital Goods
	KOF	€24.65	1.6%	-23.9%	€485.5m	€37.87	8.9	2.5%	8.9%	Consumer Durables
	OSB	UK£5.20	0.3%	4.7%	UK£1.8b	UK£6.78	6.4	6.0%	6.8%	Diversified Financials
	GAMA	UK£8.95	-3.7%	-21.8%	UK£810.2m	UK£13.99	12.5	3.5%	2.5%	Telecom
	INF	€37.55	-3.5%	-2.0%	€246.9m	€51.24	15.9	13.4%	5.3%	Software
	TCW	CA$6.99	-5.2%	51.3%	CA$1.4b	CA$8.46	13.3	7.4%	3.1%	Energy
	HITI	CA$3.32	2.8%	8.5%	CA$287.3m	CA$7.30	0.4	170.9%	n/a	Pharmaceuticals & Biotech
	IMG	CA$23.76	2.3%	139.3%	CA$13.8b	CA$36.15	9.6	5.1%	n/a	Materials
	FRP	UK£1.15	-1.7%	-8.0%	UK£279.0m	UK£2.05	12.1	13.6%	4.7%	Diversified Financials
	CADLR	NOK 52.75	-1.3%	0.09%	NOK 20.3b	NOK 70.36	6.8	14.4%	n/a	Capital Goods
	ARJO B	SEK 23.90	-2.0%	-26.0%	SEK 6.5b	SEK 30.00	18.5	21.3%	4.0%	Healthcare
	SAM	US$176.11	-3.2%	-11.1%	US$1.8b	US$230.39	0.9	38.4%	n/a	Food, Beverage & Tobacco
	ACIW	US$44.09	-2.5%	-1.1%	US$4.5b	US$65.33	21.7	19.2%	n/a	Software
	ATMU	US$51.79	4.0%	47.8%	US$4.2b	US$66.40	20.0	10.9%	0.4%	Capital Goods

Page 1 of 68